Study: Immunocompromised patients report fewer negative effects after COVID-19 mRNA vaccine booster
Immunocompromised people age 12 and older experience fewer local and systemic reactions after receiving a COVID-19 mRNA booster than after the third primary dose, the Centers for Disease Control and Prevention reports. The findings are based on responses to CDC’s voluntary V-safe virtual health check-in platform and Vaccine Adverse Event Reporting System.
Related News Articles
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…